Purchase Order 75N94021P00685
Award Date 8/16/21
Potential Completion Date 7/31/24
Potential Value $24K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $24,917.48 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for RNA isolation services. The contract is not set aside and has an ultimate completion date of June 11, 2025. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has provided various products and services...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The $7,820.97 award supports the provision of Qiagen's products and services, which include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, bioinformatics software, and precision medicine analysis tools. Qiagen has a long history...
- This is a firm fixed-price purchase order awarded to Qiagen, LLC by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $16,101.84 and a period of performance through May 11, 2024. The award does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V. Qiagen provides a range of products and services to support federal...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $15,090 contract is for the supply of unspecified products or services, with a period of performance ending on August 27, 2018. Qiagen has previously provided a range of goods and services to federal agencies, including DNA/RNA extraction kits, sequencing equipment, bioinformatics software, and other...
- This is a federal contract award to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V., by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The contract has a ceiling value of $8,159.50 and was awarded on September 12, 2016, with an ultimate completion date of April 30, 2017. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Qiagen, LLC, a foreign-owned, for-profit...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC for the provision of custom PCR arrays and reagents. The award has a ceiling value of $4,324.80 and a completion date of June 30, 2016. Qiagen, LLC is a subsidiary of the international biotechnology company Qiagen N.V., which has a history of providing specialized products and services to support...
- This federal contract award is for laboratory equipment and supplies provided by Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, with a ceiling value of $27,785.90, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of June 17, 2016. This award is not associated with a set-aside program....
- Qiagen, LLC was awarded a contract by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) on April 14, 2015, to provide RNA isolation and quantitative polymerase chain reaction (qPCR) services for 154 biological samples. The contract, issued as a Blanket Purchase Agreement (BPA) call under a firm fixed-price arrangement, has a ceiling value of approximately $14.9K and was set to conclude on April 30, 2024. The work will be performed in Valencia, California. As a BPA call, this...
- This purchase order award from the Department of Health and Human Services' National Institutes of Health Clinical Center to Qiagen, LLC is for $10,847.20 to support library preparation in next generation sequencing assays for clinical center patients. Qiagen will provide products and services for DNA/RNA extraction and sample preparation to support the agency's biomedical research and public health programs. As an international provider of molecular diagnostics technologies, Qiagen has...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $15,641.00, is for the provision of genomic research and analysis tools, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, and bioinformatics software....